Plenaxis (abarelix), a new drug for advanced prostate cancer
January 2004
Some men will be asking about Plenaxis (abarelix), a new drug for advanced prostate cancer.
Plenaxis suppresses testosterone by blocking gonadotropin-releasing hormone receptors. It doesn't cause an initial testosterone surge...like Lupron and other gonadotropin agonists.
But Plenaxis has a serious drawback...it causes life-threatening allergic reactions in almost 4% of patients.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote